Open access
Open access
Powered by Google Translator Translator

TB/Non-TB Mycobacterial infections

Summary | WHO recommendations on the treatment of drug-resistant tuberculosis, 2020 update.

9 Jun, 2021 | 08:12h | UTC

World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update – European Respiratory Review

Original Guideline: WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment – Drug-Resistant Tuberculosis Treatment

 

Commentary on Twitter

 


Practice changing | A four-month rifapentine regiment with moxifloxacin is noninferior to the standard 6-month regimen in the treatment of tuberculosis.

6 May, 2021 | 08:56h | UTC

Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis – New England Journal of Medicine

Commentary: Four-month TB treatment matches six-month standard of care – Aidsmap

 


Review and Algorithm: Tuberculosis and the Heart

31 Mar, 2021 | 03:07h | UTC

Tuberculosis and the Heart – Journal of the American Heart Association

 

Commentary on Twitter

 


M-A: Incidence and prevalence of tuberculosis in incarcerated populations

25 Mar, 2021 | 08:09h | UTC

Incidence and prevalence of tuberculosis in incarcerated populations: a systematic review and meta-analysis – The Lancet Public Health

Commentary: Tuberculosis in prisons: an unintended sentence? – The Lancet Public Health

 

Commentary on Twitter (thread – click for more)

 


[Press release – not published yet] Trial of multi drug-resistant TB treatment ends enrolment early after independent board indicates new regimen is superior

25 Mar, 2021 | 08:10h | UTC

Trial of multi drug-resistant TB treatment ends enrolment early after independent board indicates new regimen is superior – Médecins Sans Frontières

 

Commentary on Twitter

 


WHO Campaign | World Tuberculosis Day 2021: The Clock Is Ticking

24 Mar, 2021 | 08:16h | UTC

World Tuberculosis Day 2021: The Clock Is Ticking – World Health Organization

 


WHO Guideline: Screening for Tuberculosis Disease

24 Mar, 2021 | 08:13h | UTC

WHO consolidated guidelines on tuberculosis Module 2: Screening – Systematic screening for tuberculosis disease – World Health Organization

See also: WHO Operational Handbook on Systematic Screening for Tuberculosis – World Health Organization

 


World TB Day | Report: COVID-19 Eliminates Twelve Years of Progress Against Tuberculosis

24 Mar, 2021 | 08:19h | UTC

COVID-19 Eliminates Twelve Years of Progress Against Tuberculosis, Global Investment Needed – Health Policy Watch

Report: One year on, new data show global impact of covid-19 on TB epidemic is worse than expected – Stop TB Partnership

See also: 1.4 million with tuberculosis, lost out on treatment during first year of COVID-19 – United Nations

 


Testing strategies for diagnosing tuberculosis in young children

24 Feb, 2021 | 02:05h | UTC

Sensitive and Feasible Specimen Collection and Testing Strategies for Diagnosing Tuberculosis in Young Children – JAMA Pediatrics (free for a limited period)

Editorial: Diagnosing Childhood Tuberculosis: A Small Step Forward (free for a limited period)

Commentary: Diagnosing Pediatric TB in the Resource-Limited Areas – Physician’s Weekly

 


WHO announces updates on new molecular assays for the diagnosis of tuberculosis (TB) and drug resistance

21 Feb, 2021 | 22:05h | UTC

News release: WHO announces updates on new molecular assays for the diagnosis of tuberculosis (TB) and drug resistance – World Health Organization

Publication: Update on the use of nucleic acid amplification tests to detect TB and drug-resistant TB: rapid communication – World Health Organization

 


SR: How accurate are tests (Xpert Ultra and Xpert MTB/RIF) for diagnosing extrapulmonary tuberculosis and rifampicin resistance?

12 Feb, 2021 | 01:55h | UTC

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults – Cochrane Library

Summary: How accurate are tests (Xpert Ultra and Xpert MTB/RIF) for diagnosing tuberculosis outside the lungs (extrapulmonary tuberculosis) and rifampicin resistance? – Cochrane Library

 

Commentary on Twitter

 


WHO announces updated definitions of extensively drug-resistant tuberculosis

29 Jan, 2021 | 01:38h | UTC

WHO announces updated definitions of extensively drug-resistant tuberculosis – World Health Organization

Report: Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis

 


Clinical Practice Guideline: Treatment of Nontuberculous Mycobacterial Pulmonary Disease

7 Jul, 2020 | 08:53h | UTC

Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline: Executive Summary – Clinical Infectious Diseases

 


Stay Updated in Your Specialty

No spam, just news.